Clinical trial

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary…

NCT00371709 · Boston Scientific Corporation, Industry · Completed

Key facts

NCT number NCT00371709
Title TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions
Official title TAXUS ATLAS: A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions
Lead sponsor Boston Scientific Corporation, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions TAXUS Liberté-SR, TAXUS™ Express
Enrollment 871
Start date Aug 1, 2004
Primary completion Nov 1, 2005
Completion Mar 1, 2010
First posted Sep 4, 2006
Last update posted Feb 2, 2012
Countries Australia, Canada, China, New Zealand, Singapore, Taiwan, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies